When did Aclaris Therapeutics report Q4 2024 earnings?

Aclaris Therapeutics (ACRS) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Aclaris Therapeutics's Q4 2024 revenue and EPS?

Aclaris Therapeutics reported revenue of $9.2M and eps of $-0.10 for Q4 2024.

Did Aclaris Therapeutics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $7.0M by $2.2M. EPS missed the consensus estimate of $-0.09 by $0.01.

Where can I find Aclaris Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-001819) directly on SEC EDGAR. The filing index links above go to sec.gov.

Aclaris Therapeutics ACRS Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$9.2MBeat by $2.2M

EPS-$0.10Miss by $0.01

Revenue estimate$7.0M

EPS estimate-$0.09

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$1.4M

EPS estimate-$0.16

Financials

Q4 2024

Income statement

See full

Revenue$9.2M-47.6%

Gross profit$8.5M-49.5%

Operating income-$99.7M-2,363%

Net income-$96.6M-6,376%

EPS (diluted)-$1.21-5,950%

Balance sheet

See full

Cash & equivalents$24.6M-38.4%

Total debt$2.6M-25.8%

Total equity$155.6M-1.0%

Total assets$220.3M+11.6%

Cash flow

See full

Operating cash flow-$8.9M-32.2%

Free cash flow-$8.9M-24.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$265.41M+257%

Enterprise value$243.43M+541%

P/S14.2×+11.8×

Profitability

See full

Gross margin85.1%-4.0pp

Operating margin-758.1%-2,507pp

Net margin-705.4%-2,141pp

Returns & leverage

See full

Return on equity-84.5%+191pp

Debt / equity0×0.0×

Current ratio4×-0.2×

Versus estimates

Revenue

Q1 2026$2.0MBeat by $674.3K Q4 2025$1.3MMiss by $776.1K Q3 2025$3.3MBeat by $1.2M Q2 2025$1.8MBeat by $639.5K Q1 2025$1.5MMiss by $2.1M

Q4 2024$9.2MBeat by $2.2M

Diluted EPS

Q1 2026-$0.15Beat by $0.01 Q4 2025-$0.16Miss by $0.01 Q3 2025-$0.12Beat by $0.01 Q2 2025-$0.13In line Q1 2025-$0.12Beat by $0.05

Q4 2024-$0.10Miss by $0.01

Ask the moment Aclaris Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Aclaris Therapeutics report Q4 2024 earnings?: Aclaris Therapeutics (ACRS) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Aclaris Therapeutics's Q4 2024 revenue and EPS?: Aclaris Therapeutics reported revenue of $9.2M and eps of $-0.10 for Q4 2024.
Did Aclaris Therapeutics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $7.0M by $2.2M. EPS missed the consensus estimate of $-0.09 by $0.01.
Where can I find Aclaris Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-001819) directly on SEC EDGAR. The filing index links above go to sec.gov.